ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » California » Nephrology

Top Nephrology Prescribers in California

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
MARK BARATS M.D.

Nephrology

53,119

$6.26M

558
529 are 65+

4%
patients receiving schedule two controlled substances

Avg: 0%

18%
patients receiving schedule three controlled substances

Avg: 6%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

61%
prescriptions for brand name drugs

Avg: 31%

$118
Average prescription price

Avg: $116

MARK SONG MD, PHD

Nephrology

34,265

$3.63M

966
882 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

12%
patients receiving schedule three controlled substances

Avg: 6%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

53%
prescriptions for brand name drugs

Avg: 31%

$106
Average prescription price

Avg: $116

HONG KIM M.D.

Nephrology

29,930

$1.95M

784
703 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

8%
patients receiving schedule three controlled substances

Avg: 6%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

36%
prescriptions for brand name drugs

Avg: 31%

$65
Average prescription price

Avg: $116

ILYA GELMAN M.D.

Nephrology

28,116

$2.95M

508
472 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

13%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

56%
prescriptions for brand name drugs

Avg: 31%

$105
Average prescription price

Avg: $116

MINH DO M.D.

Nephrology

25,182

$1.73M

623
549 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

21%
patients receiving schedule three controlled substances

Avg: 6%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

37%
prescriptions for brand name drugs

Avg: 31%

$69
Average prescription price

Avg: $116

THANH NGUYEN MD

Nephrology

22,611

$2.71M

605
557 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

4%
patients receiving schedule three controlled substances

Avg: 6%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

61%
prescriptions for brand name drugs

Avg: 31%

$120
Average prescription price

Avg: $116

RONALD LANG M.D.

Nephrology

22,456

$1.51M

623
423 are 65+

5%
patients receiving schedule two controlled substances

Avg: 0%

13%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 31%

$67
Average prescription price

Avg: $116

PAGIEL SHECHTER M.D.

Nephrology

21,725

$1.43M

510
336 are 65+

7%
patients receiving schedule two controlled substances

Avg: 0%

27%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 31%

$66
Average prescription price

Avg: $116

JIMMY YUE

Nephrology

21,681

$1.92M

951
860 are 65+

2%
patients receiving schedule two controlled substances

Avg: 0%

6%
patients receiving schedule three controlled substances

Avg: 6%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

49%
prescriptions for brand name drugs

Avg: 31%

$88
Average prescription price

Avg: $116

BALBIR SINGH M.D.

Nephrology

17,454

$1.48M

637
487 are 65+

3%
patients receiving schedule two controlled substances

Avg: 0%

22%
patients receiving schedule three controlled substances

Avg: 6%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 31%

$85
Average prescription price

Avg: $116

SOL REISIN MD

Nephrology

16,558

$1.27M

806
709 are 65+

2%
patients receiving schedule two controlled substances

Avg: 0%

12%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 31%

$77
Average prescription price

Avg: $116

JAMBUR CHANDRASHEKAR M.D.

Nephrology

15,155

$1.28M

752
564 are 65+

2%
patients receiving schedule two controlled substances

Avg: 0%

27%
patients receiving schedule three controlled substances

Avg: 6%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 31%

$84
Average prescription price

Avg: $116

EYAL SHTORCH MD

Nephrology

14,793

$886K

485
413 are 65+

8%
patients receiving schedule two controlled substances

Avg: 0%

18%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 31%

$60
Average prescription price

Avg: $116

NIRUPAMA VEMURI MD

Nephrology

13,968

$897K

528
417 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

17%
patients receiving schedule three controlled substances

Avg: 6%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 31%

$64
Average prescription price

Avg: $116

JACK RUBIN M.D.

Nephrology

13,246

$1M

493
347 are 65+

2%
patients receiving schedule two controlled substances

Avg: 0%

21%
patients receiving schedule three controlled substances

Avg: 6%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 31%

$76
Average prescription price

Avg: $116

DANNY FARAHMANDIAN MD

Nephrology

13,183

$992K

527
453 are 65+

8%
patients receiving schedule two controlled substances

Avg: 0%

12%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 31%

$75
Average prescription price

Avg: $116

WEN-TSANG KU M.D.

Nephrology

13,038

$1.83M

617
547 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

7%
patients receiving schedule three controlled substances

Avg: 6%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

37%
prescriptions for brand name drugs

Avg: 31%

$140
Average prescription price

Avg: $116

MICHAEL BLOCK MD

Nephrology

12,165

$522K

515
457 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

8%
patients receiving schedule three controlled substances

Avg: 6%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 31%

$43
Average prescription price

Avg: $116

ADEGBENGA ADETOLA MD

Nephrology

11,994

$643K

361
230 are 65+

10%
patients receiving schedule two controlled substances

Avg: 0%

50%
patients receiving schedule three controlled substances

Avg: 6%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 31%

$54
Average prescription price

Avg: $116

MARCO MARTINEZ M.D.

Nephrology

11,936

$811K

417
317 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

16%
patients receiving schedule three controlled substances

Avg: 6%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 31%

$68
Average prescription price

Avg: $116

JACOB AHDOOT MD

Nephrology

11,911

$775K

515
452 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

6%
patients receiving schedule three controlled substances

Avg: 6%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 31%

$65
Average prescription price

Avg: $116

HAROLD BAER M.D. FACP

Nephrology

11,592

$1.71M

550
265 are 65+

3%
patients receiving schedule two controlled substances

Avg: 0%

8%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 31%

$147
Average prescription price

Avg: $116

PHILLIP NG MD

Nephrology

11,423

$908K

352
316 are 65+

8%
patients receiving schedule two controlled substances

Avg: 0%

14%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 31%

$79
Average prescription price

Avg: $116

JIM-JER HWU MD

Nephrology

11,025

$1.25M

545
442 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

3%
patients receiving schedule three controlled substances

Avg: 6%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

41%
prescriptions for brand name drugs

Avg: 31%

$114
Average prescription price

Avg: $116

CARLOS MEZA M.D.

Nephrology

10,854

$796K

479
400 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

10%
patients receiving schedule three controlled substances

Avg: 6%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 31%

$73
Average prescription price

Avg: $116

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank